Lung Cancer

Specialty

Disclaimer: This is sponsored content. All opinions and views are of the advertiser and do not reflect the same of WFTS. As technology and digital media become more prevalent in our society, our stress levels are also increasing. Modern-day stressors and fast-paced lifestyles are making it difficult for us to focus on our health. Many of us are not getting enough sleep, not eating at regular times, consuming unhealthy foods, and not drinking enough water, which can lead to a variety of health issues. Prostate-related health issues are becoming particularly common among men. Cancer of the prostate is one such disease. Studies show that about 13 out of every 100 American men will develop prostate cancer at some point in their life, and between 2 and 3 of them will die from the disease. Age is considered to be the main risk factor for prostate cancer, and some studies suggest that by the year 2124, half of all males will likely have prostate cancer. If you are someone who&

January 12, 2023 4 min read Source/Disclosures Disclosures: National Cancer Institute funded this study. Wang reports no relevant financial disclosures. Please see the study for all other authors' relevant financial disclosures. Phillips reports serving as a board member for the Thoracic Surgery Outcomes Research Network. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on .

[unable to retrieve full-text content] Keytruda wins broad adjuvant NSCLC nod to pressure Tecentriq    FiercePharma

Aesther Healthcare Acquisition Corp. Results outline novel bispecific antibody approach that generates strong anti-tumor response in malignant melanoma, holding potential to control important pathways in multiple cancer types Ocean Biomedical is expected to become a publicly traded company on the NASDAQ global market under the symbols "OCEA" and "OCEAW" following the closing of a Business Combination with Aesther Corporation Providence, RI and New York, NY, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical and Aesther Healthcare Acquisition Corp. (NASDAQ: AEHA) announced today the discovery of a second major anti-tumor pathway and therapeutic approach that targets CTLA-4, inhibiting the metastasis of malignant melanoma cells to the lung using a novel bispecific antibody approach. This major regulating mechanism discovery, recently published in Frontiers in Immunology , by Ocean Biomedical's Scientific Co-founder and Brown University's Emeritus D

[unable to retrieve full-text content] Pictures of Melanoma: Examples, Identification, and More    Healthgrades

Atypical chest pain usually feels like a burning or stabbing pain in your chest. Your heart isn't always responsible. Lung conditions, acid reflux, or cartilage inflammation can also cause chest pain. Atypical pain may occur in any area of your chest. Conversely, typical chest pain usually feels like a squeezing sensation in your chest near the sternum in the center. To treat your symptoms, doctors need to find the cause of the discomfort as atypical chest pain can occur for various reasons. This article will review what atypical chest pain is, including its many possible causes and how it differs from typical chest pain. What is atypical chest pain? Doctors define atypical chest pain as a type of chest pain that doesn't have all of the three characteristics that define typical chest pain. These characteristics are : pain or discomfort in the center of your chest pain that occurs when you're under emotional stress or during exercise pain that gets better within minutes of r

Abstract Recent therapeutic advances in breast cancer (BC) have improved survival outcomes; however, the prognosis for patients with bone metastasis (BM) remains poor. Hence, novel clinical biomarkers are needed to accurately predict BC BM as well as to promote personalized medicine. Here, we discovered a novel biomarker, TOR1B, for BM in BC patients via analysis of BC gene expression data and clinical information downloaded from open public databases. In cancer cells, we found high expression levels of TOR1B in the nucleus and endoplasmic reticulum. Regarding gene expression, the level of TOR1B was significantly upregulated in BC patients with BM ( p  < 0.05), and the result was externally validated. In addition, gene expression clearly demonstrated two distinct types of prognoses in ER- and PR-positive patients. In multivariate regression, the gene could be an independent predictor of BM in BC patients, i.e., a low expression level of TOR1B was associated with delayed metas